SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000946644-14-000019
Filing Date
2014-10-10
Accepted
2014-10-10 16:17:01
Documents
4
Period of Report
2014-11-12
Effectiveness Date
2014-10-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A hebfy2014def14a09_25x14.htm DEF 14A 1508033
2 PROXY CARD heb2014proxycard001.jpg GRAPHIC 165026
3 PROXY CARD heb2014proxycard002.jpg GRAPHIC 163677
4 HEB LOGO hebfy2014def14a092514_image1.jpg GRAPHIC 15266
  Complete submission text file 0000946644-14-000019.txt   1983562
Mailing Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103 215-988-0080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-27072 | Film No.: 141152595
SIC: 2836 Biological Products, (No Diagnostic Substances)